ImmuniWeb® Continuous Penetration Testing is a commercial penetration testing solution by ImmuniWeb. Rapid7 Metasploit is a commercial penetration testing solution by Rapid7. Features, integrations, deployment and the company behind each one, side by side.
Continuous pentesting service monitoring web apps & APIs for code changes
Penetration testing software for simulating attacks and validating vulnerabilities
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
ImmuniWeb® Continuous Penetration Testing fits if you want a cloud product.
Rapid7 Metasploit fits if you need both cloud and on-premises options.
Common questions when comparing ImmuniWeb® Continuous Penetration Testing vs Rapid7 Metasploit for penetration testing.
ImmuniWeb® Continuous Penetration Testing: Continuous pentesting service monitoring web apps & APIs for code changes. Built by ImmuniWeb.
Rapid7 Metasploit: Penetration testing software for simulating attacks and validating vulnerabilities. Built by Rapid7.
The table above shows where their features, integrations, deployment and company size fit differ.
ImmuniWeb® Continuous Penetration Testing is made by ImmuniWeb. Rapid7 Metasploit is made by Rapid7. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
Often, yes. ImmuniWeb® Continuous Penetration Testing and Rapid7 Metasploit are both Penetration Testing products, and both cover Red Team. Use the table above to see where features, deployment and company size fit differ.